+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Allergy Vaccine Market Research Report by Allergy Type, Vaccine Type, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 249 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4905049
UP TO OFF until Dec 31st 2022
The Global Allergy Vaccine Market size was estimated at USD 1,037.21 million in 2021, USD 1,153.72 million in 2022, and is projected to grow at a CAGR of 11.40% to reach USD 1,983.40 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Allergy Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Allergy Type, the market was studied across Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity, Peanut Hypersensitivity, Seasonal Allergic Rhinitis, and Tree Pollen Hypersensitivity.
  • Based on Vaccine Type, the market was studied across Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine, Peanut Allergy Vaccine, and Ragweed Allergy Immunotherapy Vaccine.
  • Based on Application, the market was studied across HIV, Oncology, and Respiratory.
  • Based on End User, the market was studied across Homecare, Hospitals, and Specialty Clinics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Allergy Vaccine market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Vaccine Market, including Aimmue Therapeutics, Inc, Alexion Pharmaceuticals, ALK Abelló A/S, Allergy Therapeutics Plc, Allertein Therapeutics, Anergis SA, Angany Inc, Aravax, Astellas Pharma Inc., Biomay AG, Capnia, Inc, Circassia Pharmaceuticals, Cytos Biotechnology AG, DBV Technologies SA, Ensi Pharama, fisher scientific, HAL Allergy Group, Immunomic Therapeutics, Inc., Jubilant Pharma N.V., LETI Pharma, Merck & Co., Inc., Novartis International AG, Sementis Ltd, Stallergenes Greer plc., and Zicam LLC.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Allergy Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Vaccine Market?
6. What is the market share of the leading vendors in the Global Allergy Vaccine Market?
7. What modes and strategic moves are considered suitable for entering the Global Allergy Vaccine Market?
Frequently Asked Questions about the Global Allergy Vaccine Market

What is the estimated value of the Global Allergy Vaccine Market?

The Global Allergy Vaccine Market was estimated to be valued at $1037.21 Million in 2021.

What is the growth rate of the Global Allergy Vaccine Market?

The growth rate of the Global Allergy Vaccine Market is 11.4%, with an estimated value of $1983.4 Million by 2027.

What is the forecasted size of the Global Allergy Vaccine Market?

The Global Allergy Vaccine Market is estimated to be worth $1983.4 Million by 2027.

Who are the key companies in the Global Allergy Vaccine Market?

Key companies in the Global Allergy Vaccine Market include Aimmue Therapeutics, Inc, Alexion Pharmaceuticals, ALK Abelló A/S, Allergy Therapeutics Plc, Allertein Therapeutics, Anergis SA, Angany Inc, Aravax and Biomay AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of allergies globally
5.1.1.2. Increasing air pollution with industrialization coupled with growing tobacco consumption
5.1.1.3. Rising awareness among consumers about the allergies
5.1.2. Restraints
5.1.2.1. Limited allergy vaccine manufacturers
5.1.3. Opportunities
5.1.3.1. Research and development for the production of specific allergy vaccine
5.1.3.2. Government and private sector initiatives in the production of vaccines
5.1.4. Challenges
5.1.4.1. Capital intensive in the production of allergy vaccines
5.2. Cumulative Impact of COVID-19
6. Allergy Vaccine Market, by Allergy Type
6.1. Introduction
6.2. Allergic Asthma
6.3. Cat Dander Allergy
6.4. Grass Pollen Hypersensitivity
6.5. Peanut Hypersensitivity
6.6. Seasonal Allergic Rhinitis
6.7. Tree Pollen Hypersensitivity
7. Allergy Vaccine Market, by Vaccine Type
7.1. Introduction
7.2. Cat Allergy Vaccine
7.3. House Dust Mite Allergy Vaccine
7.4. Injectable MPL Allergy Vaccine
7.5. Peanut Allergy Vaccine
7.6. Ragweed Allergy Immunotherapy Vaccine
8. Allergy Vaccine Market, by Application
8.1. Introduction
8.2. HIV
8.3. Oncology
8.4. Respiratory
9. Allergy Vaccine Market, by End User
9.1. Introduction
9.2. Homecare
9.3. Hospitals
9.4. Specialty Clinics
10. Americas Allergy Vaccine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Allergy Vaccine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Allergy Vaccine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Aimmue Therapeutics, Inc
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Alexion Pharmaceuticals
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. ALK Abelló A/S
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Allergy Therapeutics Plc
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Allertein Therapeutics
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Anergis SA
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Angany Inc
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Aravax
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Astellas Pharma Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Biomay AG
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Capnia, Inc
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Circassia Pharmaceuticals
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Cytos Biotechnology AG
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. DBV Technologies SA
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Ensi Pharama
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. fisher scientific
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. HAL Allergy Group
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Immunomic Therapeutics, Inc.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Jubilant Pharma N.V.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. LETI Pharma
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Merck & Co., Inc.
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Novartis International AG
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Sementis Ltd
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Stallergenes Greer plc.
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
14.25. Zicam LLC
14.25.1. Business Overview
14.25.2. Key Executives
14.25.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ALLERGY VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGY VACCINE MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL ALLERGY VACCINE MARKET DYNAMICS
FIGURE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY ALLERGY TYPE, 2027
FIGURE 14. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2021 VS 2027 (%)
FIGURE 21. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY VACCINE TYPE, 2027
FIGURE 23. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL ALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 29. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 31. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HIV, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 35. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 37. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOMECARE, 2018-2027 (USD MILLION)
FIGURE 38. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 39. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2027 (USD MILLION)
FIGURE 40. AMERICAS ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 42. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 43. AMERICAS ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 44. ARGENTINA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. BRAZIL ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. CANADA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. MEXICO ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. UNITED STATES ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 50. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 51. UNITED STATES ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 52. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 54. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 55. ASIA-PACIFIC ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 56. AUSTRALIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. CHINA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. INDIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. INDONESIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. JAPAN ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. MALAYSIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. PHILIPPINES ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. SINGAPORE ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. TAIWAN ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. THAILAND ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. VIETNAM ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 72. DENMARK ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. EGYPT ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. FINLAND ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. FRANCE ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. GERMANY ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. ISRAEL ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. ITALY ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. NETHERLANDS ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. NIGERIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. NORWAY ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. POLAND ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. QATAR ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. RUSSIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. SPAIN ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. SWEDEN ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. SWITZERLAND ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 90. TURKEY ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 92. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 93. GLOBAL ALLERGY VACCINE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 94. GLOBAL ALLERGY VACCINE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 95. GLOBAL ALLERGY VACCINE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL ALLERGY VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, BY REGION, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL ALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL ALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL ALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HIV, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HIV, BY REGION, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HIV, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOMECARE, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 56. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 57. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 58. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2027 (USD MILLION)
TABLE 59. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 60. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 61. AMERICAS ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 62. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 63. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 64. AMERICAS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 65. AMERICAS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 66. AMERICAS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 67. ARGENTINA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 68. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 69. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 70. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 71. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 72. BRAZIL ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 73. BRAZIL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 74. BRAZIL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 75. BRAZIL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 76. BRAZIL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 77. CANADA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 78. CANADA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 79. CANADA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 80. CANADA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 81. CANADA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 82. MEXICO ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 83. MEXICO ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 84. MEXICO ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 85. MEXICO ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 86. MEXICO ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 87. UNITED STATES ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 88. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 89. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 90. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 91. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 92. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 93. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 94. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 95. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 96. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 97. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 98. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 99. AUSTRALIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 100. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 101. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 102. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 103. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 104. CHINA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 105. CHINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 106. CHINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 107. CHINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 108. CHINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 109. INDIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 110. INDIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 111. INDIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 112. INDIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 113. INDIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 114. INDONESIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 115. INDONESIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 116. INDONESIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 117. INDONESIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 118. INDONESIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 119. JAPAN ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 120. JAPAN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 121. JAPAN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 122. JAPAN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 123. JAPAN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 124. MALAYSIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 125. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 126. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 127. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 128. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 129. PHILIPPINES ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 131. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 132. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 133. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 134. SINGAPORE ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 135. SINGAPORE ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 136. SINGAPORE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 137. SINGAPORE ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 138. SINGAPORE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 139. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 140. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 141. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 142. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 143. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 144. TAIWAN ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. TAIWAN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 146. TAIWAN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 147. TAIWAN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 148. TAIWAN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 149. THAILAND ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 150. THAILAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 151. THAILAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 152. THAILAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 153. THAILAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 154. VIETNAM ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 155. VIETNAM ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 156. VIETNAM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 157. VIETNAM ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 158. VIETNAM ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 165. DENMARK ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 166. DENMARK ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 167. DENMARK ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 168. DENMARK ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 169. DENMARK ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 170. EGYPT ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 171. EGYPT ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 172. EGYPT ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 173. EGYPT ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 174. EGYPT ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 175. FINLAND ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 176. FINLAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 177. FINLAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 178. FINLAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 179. FINLAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 180. FRANCE ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 181. FRANCE ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 182. FRANCE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 183. FRANCE ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 184. FRANCE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 185. GERMANY ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 186. GERMANY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 187. GERMANY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 188. GERMANY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 189. GERMANY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 190. ISRAEL ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 191. ISRAEL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 192. ISRAEL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 193. ISRAEL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 194. ISRAEL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 195. ITALY ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 196. ITALY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 197. ITALY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 198. ITALY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 199. ITALY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 200. NETHERLANDS ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 201. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 202. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 203. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 204. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 205. NIGERIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 206. NIGERIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 207. NIGERIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 208. NIGERIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 209. NIGERIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 210. NORWAY ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 211. NORWAY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 212. NORWAY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 213. NORWAY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 214. NORWAY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 215. POLAND ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 216. POLAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 217. POLAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 218. POLAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 219. POLAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 220. QATAR ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 221. QATAR ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 222. QATAR ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 223. QATAR ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 224. QATAR ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 225. RUSSIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 226. RUSSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 227. RUSSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 228. RUSSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 229. RUSSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 230. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 231. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 232. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 233. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 234. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 235. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 236. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 237. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 238. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 239. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 240. SPAIN ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 241. SPAIN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 242. SPAIN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 243. SPAIN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 244. SPAIN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 245. SWEDEN ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 246. SWEDEN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 247. SWEDEN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 248. SWEDEN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 249. SWEDEN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 250. SWITZERLAND ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 251. SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 252. SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 253. SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 254. SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 255. TURKEY ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 256. TURKEY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 257. TURKEY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 258. TURKEY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 259. TURKEY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 265. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 266. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2027 (USD MILLION)
TABLE 267. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 268. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 269. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 270. GLOBAL ALLERGY VACCINE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 271. GLOBAL ALLERGY VACCINE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 272. GLOBAL ALLERGY VACCINE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 273. GLOBAL ALLERGY VACCINE MARKET RANKING, BY KEY PLAYER, 2021
TABLE 274. GLOBAL ALLERGY VACCINE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 275. GLOBAL ALLERGY VACCINE MARKET MERGER & ACQUISITION
TABLE 276. GLOBAL ALLERGY VACCINE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 277. GLOBAL ALLERGY VACCINE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 278. GLOBAL ALLERGY VACCINE MARKET INVESTMENT & FUNDING
TABLE 279. GLOBAL ALLERGY VACCINE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 280. GLOBAL ALLERGY VACCINE MARKET: LICENSE & PRICING

Companies Mentioned

  • Aimmue Therapeutics, Inc
  • Alexion Pharmaceuticals
  • ALK Abelló A/S
  • Allergy Therapeutics Plc
  • Allertein Therapeutics
  • Anergis SA
  • Angany Inc
  • Aravax
  • Astellas Pharma Inc.
  • Biomay AG
  • Capnia, Inc
  • Circassia Pharmaceuticals
  • Cytos Biotechnology AG
  • DBV Technologies SA
  • Ensi Pharama
  • fisher scientific
  • HAL Allergy Group
  • Immunomic Therapeutics, Inc.
  • Jubilant Pharma N.V.
  • LETI Pharma
  • Merck & Co., Inc.
  • Novartis International AG
  • Sementis Ltd
  • Stallergenes Greer plc.
  • Zicam LLC

Methodology

Loading
LOADING...